Prasinezumab Clinical Trials (2026): 3 Studies for Parkinson's Disease & Parkinsons Disease
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 Prasinezumab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Parkinson's Disease & Parkinsons Disease) and 1,606 total planned enrollment. 1 Phase 3 Prasinezumab trial and 2 Phase 2 are listed. 2 Prasinezumab clinical trials are actively recruiting at 42 U.S. sites across 25 states. Most recent activity: NCT07174310 (Jun 2031).
Where to Participate: All Prasinezumab Trial Sites in the U.S. (42 sites across 25 states)
Every actively recruiting Prasinezumabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | University of Alabama at Birmingham | Birmingham35233 | NCT07174310 | Map |
| AZ | Barrow Neurological Institute | Phoenix85013 | NCT07174310 | Map |
| CA | Neurology Center of North Orange County | Fullerton92835 | NCT07174310 | Map |
| CA | Keck School of Medicine of USC | Los Angeles900033 | NCT07174310 | Map |
| CA | UCLA Neurology Outpatient Clinic | Los Angeles90095 | NCT07174310 | Map |
| CA | Parkinson?s Research Centers of America ? Palo Alto | Palo Alto94301 | NCT07174310 | Map |
| CA | Profound Research LLC at The Neurology Center of Southern California | Pasadena91105 | NCT07174310 | Map |
| CA | UCSF Weill Institute for Neurosciences | San Francisco94158 | NCT07174310 | Map |
| CO | Rocky Mountain Movement Disorders | Englewood80113 | NCT07174310 | Map |
| CT | Institute for Neurodegenerative Disorders | New Haven06510 | NCT07174310 | Map |
| DC | Georgetown University | Washington D.C.20007 | NCT07174310 | Map |
| FL | JEM Research LLC | Atlantis33462 | NCT07174310 | Map |
| FL | Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton33486 | NCT07174310 | Map |
| FL | K2 - Villages | Lady Lake32159 | NCT07174310 | Map |
| FL | K2 Medical Research-Maitland | Maitland32751 | NCT07174310 | Map |
| FL | Baptist Hospital of Miami | Miami33176 | NCT07174310 | Map |
| FL | Charter Research - Winter Park/Orlando | Orlando32803 | NCT07174310 | Map |
| HI | Hawaii Pacific Neuroscience | Honolulu96817 | NCT07174310 | Map |
| IL | Northwestern University Feinberg School Of Medicine | Chicago60611 | NCT07174310 | Map |
| KS | University of Kansas Medical Center | Kansas City66160 | NCT07174310 | Map |
| MA | Massachusetts General Hospital | Boston02114 | NCT07174310 | Map |
| MI | Quest Research Institute | Farmington Hills48334 | NCT07174310 | Map |
| MO | Washington Uni School of Medicine | St Louis63110 | NCT07174310 | Map |
| NV | Cleveland Clinic Lou Ruvo | Las Vegas89106 | NCT07174310 | Map |
| NV | Renown Health | Reno89502 | NCT07174310 | Map |
| NJ | Hackensack University Medical Center;Department of Neurology, Neuroscience Institute | Paramus07652 | NCT07174310 | Map |
| NM | University of New Mexico | Albuquerque87106 | NCT07174310 | Map |
| NY | Dent Neurological Institute | Amherst14226 | NCT07174310 | Map |
| NY | Parkinson's Research Centers of America - Long Island | Commack11725 | NCT07174310 | Map |
| NY | Weill Cornell Medical College | New York10021 | NCT07174310 | Map |
| NC | Asheville Neurology | Asheville28806 | NCT07174310 | Map |
| OH | NeuroCare Center | Canton44718 | NCT07174310 | Map |
| OH | Cleveland Clinic | Cleveland44195 | NCT07174310 | Map |
| OK | The Movement Disorder Clinic of Oklahoma | Tulsa74136 | NCT07174310 | Map |
| PA | University Pennsylvania Hospital | Philadelphia19107 | NCT07174310 | Map |
| PA | Allegheny General Hospital | Pittsburgh15212 | NCT07174310 | Map |
| TN | Veracity Neuroscience | Memphis38157 | NCT07174310 | Map |
| TX | Texas Neurology PA | Dallas75206 | NCT07174310 | Map |
| TX | Central Texas Neurology Consultants | Round Rock78681 | NCT07174310 | Map |
| VA | University of Virginia Health System | Charlottesville22903 | NCT07174310 | Map |
| VA | VCU Health North Hospital | Richmond23298 | NCT07174310 | Map |
| WV | West Virginia University | Morgantown26506 | NCT07174310 | Map |
Prasinezumab clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | not yet recruiting | Total |
|---|---|---|---|---|
| P2 | 1 | 1 | 2 | |
| P3 | 1 | 1 |
Recruiting Prasinezumab clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07174310 | PARAISOA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | P3 | Parkinson's Disease | 900 | Nov 2025 |
| NCT07055087 | PreCoDePrevent Cognitive Decline in GBA-associated Parkinson's Disease | P2 | Parkinson's Disease | 120 | Dec 2025 |
Prasinezumab clinical trials by indication
Parkinson's Disease (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07174310 | PARAISO | P3 | recruiting | A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease |
| NCT07055087 | PreCoDe | P2 | not yet recruiting | Prevent Cognitive Decline in GBA-associated Parkinson's Disease |
Parkinsons Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04777331 | PADOVA | P2 | active not recruiting | A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease |
Prasinezumab pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| PARAISO | NCT07174310 | P3 | recruiting | Parkinson's Disease | 900 | — |
| PreCoDe | NCT07055087 | P2 | not yet recruiting | Parkinson's Disease | 120 | — |
| PADOVA | NCT04777331 | P2 | active not recruiting | Parkinsons Disease | 586 | — |
All Prasinezumab trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07174310 | PARAISO | A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | P3 | recruiting | 900 | Hoffmann-La Roche | Nov 2025 |
| NCT07055087 | PreCoDe | Prevent Cognitive Decline in GBA-associated Parkinson's Disease | P2 | not yet recruiting | 120 | University Hospital Tuebingen | Dec 2025 |
| NCT04777331 | PADOVA | A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease | P2 | active not recruiting | 586 | Hoffmann-La Roche | May 2021 |
Prasinezumab clinical trials: frequently asked questions
- How many Prasinezumab clinical trials are there?
- 3 Prasinezumab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Prasinezumab clinical trials recruiting in 2026?
- Yes — 1 Prasinezumab trial is actively recruiting in 2026, with 42 U.S. sites across 25 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Prasinezumab being studied for?
- Prasinezumab is being studied for Parkinson's Disease, Parkinsons Disease. The trials are grouped by indication on this page.
- What phase is Prasinezumab in?
- Prasinezumab clinical trials span 1 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Prasinezumab clinical trials?
- The lead sponsor across the most Prasinezumab trials is Hoffmann-La Roche, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Prasinezumabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: